# AstraZeneca signs $2 billion agreement with Quell to develop cell therapies
Published: 2023-06-09
Category: Headlines
Category URL: https://assetdigest.com/category/headlines/
URL: https://assetdigest.com/astrazeneca-signs-2-billion-agreement-with-quell-to-develop-cell-therapies/

![undefined](https://prod.superblogcdn.com/site_cuid_cm5qsx4iq004fwirg99umbncl/images/2023-06-09t080503z2lynxmpej58078rtroptp4astrazeneca-quell-therapeutics-autoimmune-1737053340175-compressed.jpg)

## AstraZeneca signs $2 billion agreement with Quell to develop cell therapies   (Reuters) – AstraZeneca said on Friday it had signed an agreement with Quell Therapeutics potentially worth more than $2 billion to develop cell therapies that could cure autoimmune diseases.    The agreement includes developing, manufacturing and commercialising cell therapies that have the potential to be curative in type 1 diabetes and inflammatory bowel disease indications, the drugmaker said in a statement.    UK-based Quell will receive $85 million upfront from AstraZeneca, and is also eligible to receive over $2 billion for further development and commercialisation milestones, the company added.        (Reporting by Radhika Anilkumar in Bengaluru; Editing by Rashmi Aich)


---
This blog is powered by Superblog. Visit https://superblog.ai to know more.
---